Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes.

Nature Communications
Julia K GoodrichMiriam S Udler

Abstract

Hundreds of thousands of genetic variants have been reported to cause severe monogenic diseases, but the probability that a variant carrier develops the disease (termed penetrance) is unknown for virtually all of them. Additionally, the clinical utility of common polygenetic variation remains uncertain. Using exome sequencing from 77,184 adult individuals (38,618 multi-ancestral individuals from a type 2 diabetes case-control study and 38,566 participants from the UK Biobank, for whom genotype array data were also available), we apply clinical standard-of-care gene variant curation for eight monogenic metabolic conditions. Rare variants causing monogenic diabetes and dyslipidemias display effect sizes significantly larger than the top 1% of the corresponding polygenic scores. Nevertheless, penetrance estimates for monogenic variant carriers average 60% or lower for most conditions. We assess epidemiologic and genetic factors contributing to risk prediction in monogenic variant carriers, demonstrating that inclusion of polygenic variation significantly improves biomarker estimation for two monogenic dyslipidemias.

References

May 29, 1998·The New England Journal of Medicine·A Tybjaerg-HansenB G Nordestgaard
Sep 29, 2001·The New England Journal of Medicine·S S FajansK S Polonsky
Sep 23, 2003·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Joël Zlotogora
Aug 17, 2004·Clinical Chemistry·Amanda J WhitfieldJohn R Burnett
Nov 6, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Anne Tybjaerg-HansenBørge G Nordestgaard
Apr 1, 2008·Journal of Lipid Research·Andrew S PetersonStephen G Young
Apr 28, 2010·Journal of Lipid Research·Daphna Weissglas-Volkov, Päivi Pajukanta
Jul 5, 2012·Human Genetics·Hugues AschardKristel Van Steen
May 15, 2013·Current Cardiology Reports·Peter O Kwiterovich
Jun 22, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Robert C GreenUNKNOWN American College of Medical Genetics and Genomics
Jan 21, 2014·Proceedings of the National Academy of Sciences of the United States of America·Or ZukEric S Lander
Feb 11, 2014·American Journal of Human Genetics·Leslie A LangeUNKNOWN NHLBI Grand Opportunity Exome Sequencing Project
Oct 31, 2014·Genetics in Medicine : Official Journal of the American College of Medical Genetics·UNKNOWN ACMG Board of Directors
Feb 3, 2015·Nature Genetics·Brendan K Bulik-SullivanBenjamin M Neale
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsUNKNOWN ACMG Laboratory Quality Assurance Committee
May 12, 2015·Nature Genetics·Ida SurakkaUNKNOWN ENGAGE Consortium
May 28, 2015·The New England Journal of Medicine·Heidi L RehmUNKNOWN ClinGen
Oct 3, 2015·American Journal of Human Genetics·Bjarni J VilhjálmssonAlkes L Price
Oct 4, 2015·Nature·UNKNOWN 1000 Genomes Project ConsortiumGonçalo R Abecasis
Jun 9, 2016·Genome Biology·William McLarenFiona Cunningham
Nov 11, 2016·Science Translational Medicine·Pradeep NatarajanRobert C Green
Apr 14, 2017·Current Cardiology Reports·Mahtab SharifiSteve E Humphries
Jun 2, 2017·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Shan YangScott Topper
Oct 14, 2017·Nature Communications·Kashyap A PatelMichael N Weedon
Dec 30, 2017·JAMA Oncology·Steven Sorscher
Sep 8, 2018·Human Mutation·Ahmad N Abou TayounUNKNOWN ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI)
Oct 12, 2018·Nature·Clare BycroftJonathan Marchini

❮ Previous
Next ❯

Software Mentioned

ClinGen
gnomAD
gePS
Ensembl Effect Predictor ( VEP ) Effect Estimator
ClinGen Variant Curation Interface
UCSC genome browser
ClinVar
LDpred
EPACTS
Hail

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Journal of Medical Genetics
C O Carter
Deutsche medizinische Wochenschrift
T Maier, J Hoyer
BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology
K E Davies, K J Robson
© 2021 Meta ULC. All rights reserved